14 Feb, 2023 03:27 PM
Highlights:
-- Interim revenue increased by 36% to $2.6m as net loss improved materially by ~$1.5m
-- Contract wins in US and Australia, expanded suite of offerings, lower costs and contribution...read more
31 Jan, 2023 09:02 AM
MELBOURNE, AUSTRALIA 31 January 2023: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer treat...read more
17 Jan, 2023 09:47 AM
The securities of Arovella Therapeutics Limited (‘ALA’) will be placed in trading halt at the request of ALA, pending it releasing an announcement. Unless ASX decides otherwise, the secu...read more
13 Dec, 2022 10:32 AM
Careteq Limited (ASX: CTQ, “Careteq” or the “Group”) is pleased to announce that its cash position has been bolstered by the receipt of $947,123 from the Australian Taxation ...read more
29 Nov, 2022 12:59 PM
MELBOURNE, AUSTRALIA 29 NOVEMBER 2022: Arovella Therapeutics Limited (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell platform, is leas...read more
07 Nov, 2022 10:14 AM
MELBOURNE, AUSTRALIA 7 November 2022: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell platform to treat cancer, is plea...read more